Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 4, 2015New England Journal of MedicineOpen Access

Valganciclovir for Symptomatic Congenital Cytomegalovirus Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

DKDavid W. KimberlinUniversity of Alabama at BirminghamPJPenelope JesterThe Ohio State UniversityPSPablo J. SánchezNationwide Children's Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kimberlin et al. (2015) studied this question.

synapsesocial.com/papers/6ab217c9f5301af81bf92d95https://doi.org/10.1056/nejmoa1404599
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pharmacokinetic and Pharmacodynamic Assessment of Oral Valganciclovir in the Treatment of Symptomatic Congenital Cytomegalovirus Disease2008 · 307 citations
  2. 2Symptomatic Congenital Cytomegalovirus1982 · 137 citations
  3. 3Congenital Cytomegalovirus Infection: Clinical Outcome2013 · 409 citations